Patient enrollment challenges in clinical trials are extremely common, impacting up to 85% of trials and causing study costs to skyrocket. When our partner designed a Type 1 Diabetes clinical trial, it required participants to have previously used specific medications, vastly limiting patient options within their own databases.

Halfway through the CRO’s planned annulment timeline, it became clear that the patients available in the sites’ databases simply wouldn’t be enough. That’s when they chose to partner with AutoCruitment (a life sciences company that accelerates patient enrollment for clinical trials with a direct-to-patient digital recruitment approach).

This trial is not an anomaly, but rather, the norm: CROs struggle to hit or exceed their enrollment targets. But the right patient enrollment company will identify bottlenecks and deploy a targeted, multi-faceted strategy to accelerate clinical trial enrollment for CROs and improve patient qualification outcomes.